Diphenyleneiodonium chloride

SKU:BHB21900046
Research Validated
Overview
Click light‑blue chips for details
Diphenyleneiodonium chloride (CAS 4673-26-1) is an activator supplied as a solid. Relevant to Membrane Transporter/Ion Channel and Neuronal Signaling research. Molecular formula C12H8ClI, molecular weight 314.55 g/mol.
Purity 99.88%
CAS Number 4673-26-1
Molecular Weight 314.55 g/mol
Form Solid
Storage 4°C as supplied; in solvent -80°C
Options selector
Catalog no. Size
HY-100965-5MG 5 mg
HY-100965-10MG 10 mg
HY-100965-25MG 25 mg
HY-100965-50MG 50 mg
HY-100965-100MG 100 mg
HY-100965-500MG 500 mg
HY-100965-1G 1 g
HY-100965-5G 5 g
HY-100965-10G 10 g
HY-100965-1MLX10MM 1 mL x 10 mM (in DMSO)
Available Options

Select the variant that best fits your experiment. Availability and lead time may vary by option.

  • Options: Size: 5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 500 mg, 1 g, 5 g, 10 g, 1 mL x 10 mM (in DMSO)
  • Lead time: varies by selected option.
  • Storage: 4°C, sealed storage, away from moisture. In solvent: -80°C, 1 year; -20°C, 6 months (sealed storage, away from moisture).
  • Shipping: Room temperature in continental US; may vary elsewhere.
  • Upon receipt: refrigerate at 4°C as soon as possible.
Field Specification
Alternative names DPI
CAS no. 4673-26-1
Applications
  • Functional Assay (In Vitro)
Molecular weight 314.55
Molecular formula C12H8ClI
Purity 99.88%
SMILES C12=CC=CC=C1C3=CC=CC=C3[I+]2.[Cl-]
Form Solid
Storage 4°C, sealed storage, away from moisture. In solvent: -80°C, 1 year; -20°C, 6 months (sealed storage, away from moisture).
Shipping Room temperature in continental US; may vary elsewhere.
Catalog no. (Mfr.) HY-100965
Main SKU BHB21900046
Activators

Compound Overview

Diphenyleneiodonium chloride, also known as DPI, is an inhibitor of NADPH oxidase (NOX) that also functions as a TRPA1 activator, with an EC50 of 1 to 3 μM. It selectively inhibits intracellular reactive oxygen species. It is supplied as a white to off-white solid (C12H8ClI, MW 314.55) at 99.88% purity.

Physical & Chemical Properties

CAS Number 4673-26-1
Molecular Formula C12H8ClI
Molecular Weight 314.55 g/mol
Purity 99.88%
Appearance Solid
Color White to off-white
SMILES C12=CC=CC=C1C3=CC=CC=C3[I+]2.[Cl-]
Signaling Pathway Membrane Transporter/Ion Channel; Neuronal Signaling; Metabolic Enzyme/Protease; Immunology/Inflammation; NF-κB
Solubility In Vitro: DMSO: 3.33 mg/mL (10.59 mM; Requires sonication and warming and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO) H2O: < 0.1 mg/mL (insoluble)
Storage 4°C, sealed storage, away from moisture. In solvent: -80°C, 1 year; -20°C, 6 months (sealed storage, away from moisture).
Shipping Room temperature in continental US; may vary elsewhere.

Biological Activity

Activity & Target

NOX[1] EC50: 1 to 3 μM (TRPA1)[1]

Literature Cited

Sources cited in this description and in the In Vitro & In Vivo Data tab. Peer-reviewed publications that used this product are listed under References.

[1]. Suzuki H, et al. The NADPH oxidase inhibitor diphenyleneiodonium activates the human TRPA1 nociceptor. Am J Physiol Cell Physiol. 2014 Aug 15;307(4):C384-94.

[2]. He YF, et al. Diphenyleneiodonium protects preoligodendrocytes against endotoxin-activated microglial NADPH oxidase-generated peroxynitrite in a neonatal rat model of periventricular leukomalacia. Brain Res. 2013 Jan 25;1492:108-21.

Safety

For Research Use Only. Not for use in diagnostic or therapeutic procedures, and not for human or veterinary use. Handle in accordance with the Safety Data Sheet and your institution's chemical hygiene plan.

In Vitro

SolventSolubilityNotes
DMSO3.33 mg/mL (10.59 mM)requires sonication and warming and heat to 60°C; use freshly opened DMSO (absorbed moisture lowers solubility)
H2O< 0.1 mg/mLinsoluble

Aliquot the stock solution and store it at -80°C (up to 1 year) or -20°C (up to 6 months); sealed storage, away from moisture; avoid repeated freeze-thaw cycles.

In Vivo

Choose the formulation that suits the animal model and route of administration; percentages are volume ratios of the final working solution. Start from a clear DMSO stock (see In Vitro above), add the co-solvents one at a time in the order listed, mixing after each addition, and prepare the working solution fresh on the day of dosing. If precipitation or phase separation occurs, gentle warming or sonication can help.

Protocol 1

Composition10% DMSO + 40% PEG300 + 5% Tween-80 + 45% saline
Result≥ 0.33 mg/mL (1.05 mM); clear solution
How to prepareGives a clear solution at ≥ 0.33 mg/mL (saturation not determined). For 1 mL of working solution: add 100 μL DMSO stock (3.3 mg/mL) to 400 μL PEG300; then 50 μL Tween-80; then 450 μL saline to bring the volume to 1 mL. Saline: dissolve 0.9 g sodium chloride in ddH2O and make up to 100 mL.

Protocol 2

Composition10% DMSO + 90% Corn Oil
Result≥ 0.33 mg/mL (1.05 mM); clear solution
How to prepareGives a clear solution at ≥ 0.33 mg/mL (saturation not determined). Use with caution if continuous dosing will exceed two weeks. For 1 mL of working solution: add 100 μL DMSO stock (3.3 mg/mL) to 900 μL corn oil.

Direct preparation of the working solution

These formulations are prepared directly, without a DMSO stock; use them promptly after preparation.

Protocol 3

Composition50% PEG300 + 50% saline
Result10 mg/mL (31.79 mM); suspension; requires sonication

Data provided by the manufacturer.

In Vitro

Diphenyleneiodonium chloride is an inhibitor of NADPH oxidase (NOX) and a TRPA1 activator as well (EC50 of 1 to 3 μM). Applied to HEK-TRPA1 cells at 0.03 to 10 μM, Diphenyleneiodonium chloride effectively induces a Ca2+ response, but it evokes no Ca2+ response in control HEK cells, even at the relatively high dose of 10 μM[1]. Including Diphenyleneiodonium chloride in the co-cultures significantly inhibits lipopolysaccharide (LPS)-induced preOL apoptosis. Diphenyleneiodonium chloride treatment significantly attenuates LPS-induced O2- production by 2.0-fold, bringing it to within 27% of the controls[2].

In Vivo

Intraplantar injection of Diphenyleneiodonium chloride (2 mM) into the hindpaw causes licking or biting behavior[1]. Given immediately or 24 h after lipopolysaccharide (LPS) injection, Diphenyleneiodonium chloride significantly attenuates the LPS-induced loss of O4 positive cells. Treatment either immediately or 24 h after LPS injection also significantly ameliorates LPS-induced disorganization of white matter nerve fibers. Treatment with DPI at 48 h after LPS injection, in contrast, does not appear to correct the LPS-induced white matter damage. DPI given immediately or 24 h after LPS injection significantly reduces accumulation of both gp91phox and p67phox in the membrane fraction[2].

Data provided by the manufacturer. Numbered citations refer to the Literature Cited list in the product description.

Cell Assay[2]

Co-culture purified microglia and preOLs in a Transwell system, with three groups: control, LPS-activated (lipopolysaccharide), and LPS plus Diphenyleneiodonium chloride. Culture microglia in Transwells over established preOL layers and expose them to LPS (100 ng/mL), LPS+Diphenyleneiodonium chloride (10 μM), or leave them untreated. After 48 h of incubation, collect the medium supernatants and cellular protein fractions from the co-cultures for further analysis[2].

Animal Administration[1]

Place ddy mice (6 to 7 wk of age) individually in transparent cages for 30 min before experiments. Inject 10 μL Diphenyleneiodonium chloride (2 mM; Kolliphor EL with 20% DMSO as solvent) intraplantarly into the right hindpaw, with or without intraperitoneal HC030031 (300 mg/kg, given 0.5 h before the Diphenyleneiodonium chloride injection; solvent: saline with 0.5% methyl cellulose). Record the time spent licking or biting the injected paw for 45 min after injection[1].

Data provided by the manufacturer. Numbered citations refer to the Literature Cited list in the product description.

Q.Why is there no price on some sizes?
A.Availability and lead time for those sizes are confirmed on inquiry. Send us the size you need and we will come back with price and lead time.
Q.Can this be used in humans or for diagnostics?
A.No. This product is supplied For Research Use Only. It is not for diagnostic or therapeutic procedures and not for human or veterinary use.

Need this compound in a format that drops straight into your assay? We can tailor formulation, chemistry, and documentation so your results stay consistent across runs and re-orders.

  • Format options: solid or pre-dissolved solution (choose solvent), target concentration, aliquots, light/moisture-protected packaging
  • Chemistry options: free base/acid vs salt forms, hydrate/solvate preference, stereoisomer control (single enantiomer or racemate), close analogs
  • Add-on labels & handles: D/¹³C/¹⁵N isotopes (LC-MS/internal standards), azide/alkyne or other functional handles for conjugation
  • QC & documentation: standard COA or enhanced analytical pack (HPLC/LC-MS/NMR), chiral purity, residual solvents, water content (KF), method-specific specs
  • Scale & continuity: mg to gram scale, bulk pricing, lot reservation, repeat-order continuity

To quote quickly, tell us: compound name + CAS/structure (SMILES or mol file), intended assay context, solvent preference, salt/stereochemistry requirements, purity/QC level, and the amount (mg–g).

Can’t find the compound you’re looking for?
Send the CAS or structure and your specs. We can help source it, suggest close equivalents, or discuss custom synthesis with the right QC documentation (RUO).

Cathepsin C promotes breast cancer lung metastasis by modulating neutrophil infiltration and neutrophil extracellular trap formation. Cancer Cell 2021 Mar 8;39(3):423-437.e7. PMID: 33450198

ATG8ylation-mediated tonoplast invagination mitigates vacuole damage. Nat Commun 2025 Jul 18;16(1):6621. PMID: 40681515

NCF4 attenuates colorectal cancer progression by modulating inflammasome activation and immune surveillance. Nat Commun 2024 Jun 17;15(1):5170. PMID: 38886341

Encountering and Wrestling: Neutrophils Recognize and Defensively Degrade Graphene Oxide. Adv Healthc Mater 2022 Apr;11(8):e2102439. PMID: 34859964

CuO-NPs-triggered heterophil extracellular traps exacerbate liver injury in chicks by promoting oxidative stress and inflammatory responses. Arch Toxicol 2022 Nov;96(11):2913-2926. PMID: 35962800

Chicken heterophils extracellular traps act as early effectors against cyclopiazonic acid dependent upon NADPH oxidase, ROS and glycolysis. Arch Toxicol 2022 Jul;96(7):2113-2122. PMID: 35508807

Appl Phys Rev. 2026 Jan 21.

Microplastics modulate neutrophil migration via an ROShistone lactylation positive feedback loop. J Hazard Mater 2025 Nov 5:499:140113. PMID: 41092707

MPTP mediated Ox-mtDNA release inducing macrophage pyroptosis and exacerbating MCD-induced MASH via promoting the ITPR3/Ca2+/NLRP3 pathway. J Transl Med 2025 Nov 14;23(1):1289. PMID: 41239426

Mitochondrial ROS driven by NOX4 upregulation promotes hepatocellular carcinoma cell survival after incomplete radiofrequency ablation by inducing of mitophagy via Nrf2/PINK1. J Transl Med 2023 Mar 25;21(1):218. PMID: 36964576

Get a Quote

Please use this form for bulk quantity requests or customized products.

Contact Information

Product Information

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today